Cornelia Liu Trimble MD

Obstetrics & Gynecology•Lutherville, MD

Professor of Gynecology and Obstetrics, Oncology, and Pathology, Johns Hopkins University School of Medicine

Join to View Full Profile

10753 Falls RoadPavilion II Suite 245Lutherville, MD 21093
Phone+1 443-997-0400
Fax+1 410-367-3312

Education & Training

Johns Hopkins UniversityResidency, Obstetrics and Gynecology, 1993 - 1997
New York Presbyterian Hospital (Cornell Campus)Residency, Pathology-Anatomic and Clinical, 1989 - 1991
Vanderbilt University School of MedicineClass of 1988

Certifications & Licensure

MD State Medical License 1990 - 2025
NY State Medical License 1991 - 1992
American Board of Obstetrics and Gynecology Obstetrics & Gynecology
American Board of Pathology Anatomic Pathology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013-2014
Top Doctors:Baltimore Area Castle Connolly, 2012
Top Doctors:Washington-Baltimore Castle Connolly, 2012
Fellow (FACOG) American Congress of Obstetricians and Gynecologists
Join now to see all

Clinical Trials

Vaccine Therapy in Preventing Cervical Cancer in Patients With Cervical Intraepithelial Neoplasia Start of enrollment: 2004 Jun 01
Completed
Phase 2
Vaccine Therapy in Preventing Cervical Cancer in Patients With Cervical Intraepithelial Neoplasia Start of enrollment: 2003 Nov 01
Completed
Phase 1, Phase 2
Megestrol in Treating Patients With Endometrial Neoplasia or Endometrial Hyperplasia Start of enrollment: 2007 Jul 01
Terminated
Phase 2
Vaccine Therapy With or Without Imiquimod in Treating Patients With Grade 3 Cervical Intraepithelial Neoplasia Start of enrollment: 2008 Nov 01
Completed
Phase 1
Therapeutic Vaccination for Patients With HPV16+ Cervical Intraepithelial Neoplasia (CIN2/3) Start of enrollment: 2009 Sep 01
Completed
Phase 1
A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3 Start of enrollment: 2011 Apr 01
Completed
Phase 2
Artesunate Ointment for the Treatment of High Grade Vulvar Intraepithelial Neoplasia (HSIL VIN2/3) Start of enrollment: 2019 Apr 17
COMPLETED
PHASE1
Artesunate Vaginal Inserts for the Treatment of Cervical Intraepithelial Neoplasia (CIN2/3) Start of enrollment: 2020 Sep 09
RECRUITING
PHASE2
Join now to see all

Publications & Presentations

PubMed

Meeting report: Considerations for trial design and endpoints in licensing therapeutic HPV16/18 vaccines to prevent cervical cancer.
Peter M Dull, Sharon L Achilles, Rafi Ahmed, Ruanne V Barnabas, Nicole G Campos
Vaccine. 2024-11-14
3 citations
Safety and efficacy of topical artesunate for the treatment of vulvar intraepithelial neoplasia 2/3.
Chad M Michener, Stephanie Ricci, Mariam AlHilli, Lindsey Beffa, Robert Debernardo
Gynecologic Oncology. 2023-11-01
7 citations
A phase I study of intra-anal artesunate (suppositories) to treat anal high-grade squamous intraepithelial lesions.
Sandy Hwang Fang, Mihaela Plesa, Evie H Carchman, Nicole A Cowell, Emily Staudt
Plos One. 2023-01-01

Journal Articles

A First-in-Human Proof-of-Concept Trial of Intravaginal Artesunate to Treat Cervical Intraepithelial Neoplasia 2/3 (CIN2/3)
Cornelia Trimble, MD, Gynecologic Oncology
HLA and KIR Associations of Cervical Neoplasia
Cornelia Trimble, Janet S Rader, The Journal of Infectious Diseases

Press Mentions

HPV: 5 Things All Women Should KnowDecember 21st, 2022
2019 Gynecologic Cancer Survivorship Conference: Thriving Through Education and ConnectionSeptember 5th, 2019
DNA-Based Vaccine Clears Nearly Half of Precancerous Cervical Lesions in Clinical TrialSeptember 30th, 2015
Join now to see all

Grant Support

Immunomodulatory effects of topical artesunate on cervical intraepithelial neoplasia 2/3.JOHNS HOPKINS UNIVERSITY2022–2024

Professional Memberships

American College of Obstetricians and Gynecologists
Fellow

External Links

Johns Hopkins Physicianshttp://www.hopkinsmedicine.org/cornelia-trimble